We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+5.77%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$15.4B
AUM Growth
-$1.4B
Cap. Flow
-$1.81B
Cap. Flow %
-11.71%
Top 10 Hldgs %
17.85%
Holding
1,676
New
438
Increased
307
Reduced
375
Closed
549

Top Sells

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$204M
2
MPC icon
Marathon Petroleum
MPC
+$156M
3
STLD icon
Steel Dynamics
STLD
+$130M
4
NSC icon
Norfolk Southern
NSC
+$127M
5
BKNG icon
Booking.com
BKNG
+$125M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.48%
2 Healthcare 11.94%
3 Financials 8.89%
4 Industrials 8.1%
5 Consumer Staples 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENPH icon
1126
Enphase Energy
ENPH
$4.91B
$23K ﹤0.01%
11,460
-10,440
-48% -$22.9K
PTX
1127
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$5K ﹤0.01%
+1,170
New +$7.64K
A icon
1128
CALL
Agilent Technologies
A
$43.3B
-150,000
Closed -$5.98M
AAP icon
1129
PUT
Advance Auto Parts
AAP
$2.63B
-100,000
Closed -$16M
AAT
1130
American Assets Trust
AAT
$1.41B
-20,436
Closed -$816K
ACAD icon
1131
PUT
Acadia Pharmaceuticals
ACAD
$5.11B
-10,000
Closed -$280K
ACLS icon
1132
Axcelis
ACLS
$3.81B
-4,005
Closed -$45K
ADI icon
1133
CALL
Analog Devices
ADI
$181B
-50,000
Closed -$2.96M
ADP icon
1134
CALL
Automatic Data Processing
ADP
$112B
-100,000
Closed -$8.97M
AEE icon
1135
Ameren
AEE
$29.7B
-536,778
Closed -$26.9M
AHT
1136
Ashford Hospitality Trust
AHT
$21.5M
-14
Closed -$86K
AIZ icon
1137
Assurant
AIZ
$14.2B
-202,528
Closed -$15.6M
ALNY icon
1138
Alnylam Pharmaceuticals
ALNY
$31.6B
-55,671
Closed -$3.49M
ALSN icon
1139
Allison Transmission
ALSN
$10.8B
-14,600
Closed -$394K
ALV icon
1140
Autoliv
ALV
$9.02B
-3,041
Closed -$260K
AMCX icon
1141
CALL
AMC Global Media
AMCX
$512M
-50,000
Closed -$3.25M
AME icon
1142
Ametek
AME
$55.6B
-11,275
Closed -$564K
AMT icon
1143
American Tower
AMT
$83.1B
-414,837
Closed -$42.5M
AMZN icon
1144
PUT
Amazon
AMZN
$2.83T
-700,000
Closed -$20.8M
AN icon
1145
PUT
AutoNation
AN
$6.45B
-150,000
Closed -$7M
ANET icon
1146
CALL
Arista Networks
ANET
$237B
-560,000
Closed -$2.21M
ANET icon
1147
Arista Networks
ANET
$237B
-462,400
Closed -$1.82M
ANGO icon
1148
AngioDynamics
ANGO
$652M
-15,000
Closed -$184K
ANSS
1149
DELISTED
Ansys
ANSS
-7,155
Closed -$632K
APAM icon
1150
Artisan Partners
APAM
$3.05B
-46,122
Closed -$1.42M

Similar funds

Dmitry Balyasny's Q2 2016 Portfolio in Review

As of Q2 2016, Dmitry Balyasny held 1,676 positions worth $15.4B, down 8.3% from $16.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Dmitry Balyasny withdrew a net $1.81B in Q2 2016, closing 549 positions and reducing 375 holdings. Its most notable exit was Booking.com, an estimated $125M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Dmitry Balyasny opened a new position in Union Pacific worth $183M.

  • Dmitry Balyasny's largest Q2 2016 buy was Union Pacific: 2,095,751 shares worth $183M.
  • Dmitry Balyasny added most to Alibaba in Q2 2016, an estimated $149M increase.
  • Dmitry Balyasny's biggest Q2 2016 reduction was CSX Corp, cutting an estimated $204M.
  • Dmitry Balyasny fully exited Booking.com in Q2 2016, selling an estimated $125M.
  • Dmitry Balyasny's ten largest holdings make up 18% of its $15.4B portfolio in Q2 2016.
  • Dmitry Balyasny opened 438 new positions and closed 549 in Q2 2016.
  • Dmitry Balyasny's portfolio value fell 8.3% quarter-over-quarter to $15.4B.

Based on Balyasny Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.